07.Apr .2021 20:00

EMA finds possible link between AstraZeneca jab and rare cases of unusual blood clots

EMA finds possible link between AstraZeneca jab and rare cases of unusual blood clots
Back

Most of the cases of blood clot disorders occurred in people below 60 years of age and in women within two weeks of vaccination, but the EMA concluded that age and gender are not determining factors for these rare reactions to the jab, Sabine Straus, head of the EMA’s Pharmacovigilance Risk Assessment Committee (Prac), said.
 
She said:
 
"This vaccine has proven to be highly effective, it prevents severe disease and hospitalization and it is saving lives. Vaccination is extremely important in helping us in the fight against Covid-19 and we need to use the vaccines we have to protect us from the devastating effects.
 
Prac, after a very in-depth analysis, has concluded that the reported cases of unusual blood clotting following vaccination of the AstraZeneca vaccine should be listed as possible side effects of the vaccine," - she added when pressed about the risks of getting the vaccine and concerns about blood clots:
 
"The frequency [of these rare side effects] is difficult to assess, but we feel if you state the reporting rate is approximately one in 100,000 or even a little bit higher, that would reflect the risk.
 
Based on that information we ask national vaccination authorities to make up their mind on who they would like to vaccinate with which kind of vaccine."
 
Source: The Guardian